Skip to Content


In the US, Argatroban (argatroban systemic) is a member of the drug class thrombin inhibitors and is used to treat Thrombotic/Thromboembolic Disorder.

US matches:

UK matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

Anticoagulant agent: Direct thrombin inhibitor

Chemical Name

(2R,4R)-4-Metyl-1-[(S)-N²-[[(RS)-1,2,3,4-tetrahydro-3-metyl-8-quinolyl]sulfonyl]arginyl]pipecolic acid

Foreign Names

  • Argatrobanum (Latin)
  • Argatroban (German)
  • Argatroban (French)
  • Argatroban (Spanish)

Generic Names

  • Argatroban (OS: USAN, BAN)
  • Argipidine (IS)
  • MQPA (IS)
  • Argatroban Hydrate (OS: JAN)
  • DK 7419 (IS)
  • GN 1600 (IS)
  • MCI 9038 (IS: Mitsubishi)
  • MD 805 (IS: Mitsubishi)
  • OM 805 (IS)
  • Argatroban Hydrate (PH: JP XVI)

Brand Names


BANBritish Approved Name
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.